Abbott reports positive preliminary data for IRIDICA Abbott announced initial results that suggest its innovative testing platform, known as IRIDICA, produces results consistent with the current standard of care in just hours. Currently, the diagnosis of serious infections, such as sepsis or pneumonia, can often take several days. The data from the RApid Diagnosis of Infections in the CriticAlly IlL study promises to provide new hope for critically ill patients with infections – and potentially change the way infections are diagnosed around the world.
News For ABT From The Last 14 Days
Check below for free stories on ABT the last two weeks.